Shared Content Block:
Styles -- modify testimonial colors
The mission of the RNA Bioscience Initiative (RBI) is to cultivate a vibrant center of discovery and innovation in RNA biology, informatics, diagnostics, and therapy. Our goal is to provide a fluid pipeline from basic to clinical RNA research at the Anschutz Medical Campus.
.jpg?sfvrsn=b2878eb9_2 "Coronavirus and RNA (500 x 280)")
December 17, 2020
It took decades of basic research on RNA to lay the foundation for two groundbreaking vaccines that will touch the lives of hundreds of millions of people this year. Both the Pfizer and Moderna vaccines use messenger RNA, or mRNA, to encode information that helps the body recognize and fight the novel coronavirus.
.jpg?sfvrsn=64878eb9_2 "Jennifer Doudna (500 x 280)")
October 7, 2020
Jennifer Doudna, who studied RNA at the University of Colorado's Boulder campus in the 1990s, was co-recipient of the 2020 Nobel Prize in Chemistry for her work on the gene-editing technology CRISPR-Cas9.
February 18, 2021
Steve Bonilla, a postdoctoral fellow in the Kieft Lab, was selected as one of 21 early career researchers recognized by the Howard Hughs Medical Institute (HHMI) as Hanna H. Gray Fellows. Bonilla will receive up to $1.4 million over eight years to expand
his ground-breaking work using cryogenic electron microscopy to visualize dynamic RNA structures.
Read More
February 8, 2021
Congratulations to former RBI Scholar, Katie Yergert, whose manuscript is featured as the cover piece for the current issue of Plos Biology. Katie was an RBI Scholar for the 2018-2019 year, and is currently working as a Postdoctoral Fellow in Dr. Gary Bassell's laboratory at Emory University.
January 1, 2021
Congratulations to Roberto Castro-Gutierrez, Raeann Goering, Divya Kolakada, Nicole Moss, and Matthew Szucs the RBI 2020-2021 RNA Scholars. These five graduate students were selected from a pool of 9 accomplished applicants. Each displays outstanding promise toward advancing RNA biology.
Vicens and Kieft Awarded R21 via NIH-NIAID
December 15, 2020
Congratulations to Dr. Quentin Vicens and Dr. Jeffrey Kieft who were awarded an R21 through NIAID. They will be studying viral RNAs resistant to exoribonucleases in the alphavirus supergroup.
November 17, 2020
Congratulations to Dr. Randall Cohrs who was awarded an R01 through NIAID. The goal of Dr. Cohr's project is to study transcription of VLT and ORF 63 to provide insight into molecular mechanisms that regulate VZV latency and reactivation, which will allow his lab to develop novel intervention strategies that effectively target latent VZV and consequently the burden of herpes zoster disease.
The RBI has made CU Anschutz a clear hub of RNA biology expertise, raising the status of the university and its researchers in the eyes of scientists at institutions around the country and the world. The RBI sets CU Anschutz up as a leader in the exciting and groundbreaking field of RNA biology.
.jpg?sfvrsn=60498fb9_4 "Amy Campbell, PhD")
Amy Campbell
PhD